Patents by Inventor Louis Jean-Denis

Louis Jean-Denis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170312360
    Abstract: The present invention relates to a method of treating patients suffering from cancers driven by deregulated Human Epidermal Growth Factor Receptor (HER/Human EGFR), wherein an irreversible tyrosine kinase inhibitor (TKI) is administered according to a continuous regimen based on an average daily dose in the range of 10 to 50 mg and the mAB is co-administered according to a dosing regimen ranging from an average weekly iv dose of 50 to 500 mg/m2 repeated thrice, twice or once a week, once in two weeks, once in three weeks or at least monthly to a patient in need of such treatment.
    Type: Application
    Filed: July 20, 2017
    Publication date: November 2, 2017
    Inventors: Louis Jean DENIS, Robert Michael LORENCE, Mehdi SHAHIDI, Flavio SOLCA
  • Patent number: D639702
    Type: Grant
    Filed: February 11, 2010
    Date of Patent: June 14, 2011
    Inventor: Louis Jean-Denis